Literature DB >> 8096193

Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells.

M Piacentini1, L Fesus, G Melino.   

Abstract

We report the induction of apoptosis in a human neuroblastoma cell line SK-N-BE(2) by cisplatin or retinoic acid, and its relation to cell cycle. Apoptosis was monitored by counting apoptotic bodies and evaluating the activity of 'tissue' transglutaminase (EC 2.3.2.13), one of the genes specifically expressed in apoptotic cells. Data indicate that both agents enhance apoptosis, even though cells arrest at different cell cycle phases. In fact, retinoic acid causes accumulation in G1, whilst cisplatin induces accumulation of cells in the G2/M phase. This evidence suggests the presence of multiple start points for the apoptotic death programme within the cell cycle of human neuroblastoma cells.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8096193     DOI： 10.1016/0014-5793(93)80081-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Retinoids and the control of growth/death decisions in human neuroblastoma cell lines.

Authors:  G Melino; C J Thiele; R A Knight; M Piacentini
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cells.

Authors:  W Wang; C Jones; J Ciacci-Zanella; T Holt; D G Gilchrist; M B Dickman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.

Authors:  Carly St Germain; Nima Niknejad; Laurie Ma; Kyla Garbuio; Tsonwin Hai; Jim Dimitroulakos
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

4.  Lovastatin induces neuronal differentiation and apoptosis of embryonal carcinoma and neuroblastoma cells: enhanced differentiation and apoptosis in combination with dbcAMP.

Authors:  Danielle E Arnold; Celine Gagne; Nima Niknejad; Michael W McBurney; Jim Dimitroulakos
Journal:  Mol Cell Biochem       Date:  2010-08-09       Impact factor: 3.396

5.  Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.

Authors:  Catia Cemeus; Tong T Zhao; Gordon M Barrett; Ian A Lorimer; Jim Dimitroulakos
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

6.  Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.

Authors:  Angela J Mantha; Kathryn E McFee; Nima Niknejad; Glenwood Goss; Ian A Lorimer; Jim Dimitroulakos
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-26       Impact factor: 4.553

7.  Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.

Authors:  G Melino; M Annicchiarico-Petruzzelli; L Piredda; E Candi; V Gentile; P J Davies; M Piacentini
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

8.  cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines.

Authors:  M G Ormerod; C O'Neill; D Robertson; L R Kelland; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

9.  Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression.

Authors:  H Koizumi; M Wakisaka; K Nakada; T Takakuwa; T Fujioka; N Yamate; T Uchikoshi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid.

Authors:  M Inomata; N Saijo; K Kawashima; A Kaneko; Y Fujiwara; H Kunikane; Y Tanaka
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.